Stocklytics Platform
Asset logo for symbol DRRX
Durect
DRRX50
$1.34arrow_drop_down2.18%-$0.03
Penny Stock
Asset logo for symbol DRRX
DRRX50

$1.34

arrow_drop_down2.18%

Performance History

Chart placeholder
Key Stats
Open$1.35
Prev. Close$1.37
EPS-0.61
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$41.59M
PE Ratio-
LOWHIGH
Day Range1.27
1.39
52 Week Range0.47
3.14
Ratios
EPS-0.61

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Durect (DRRX)

Durect Corp (DRRX) is a pharmaceutical company that specializes in the development of innovative therapies for the treatment of various diseases. The company has a strong track record of bringing novel products to market, and its stock price history reflects this success. Over the past few years, Durect Corp's stock price has experienced steady growth, with occasional fluctuations. This can be attributed to a combination of factors, including positive clinical trial results, regulatory approvals, and commercial launches of its products. Investors who purchased Durect Corp stock during this period have witnessed significant gains in their investment.
As of the latest quote, Durect Corp's stock is trading at a favorable price. This suggests that the market has recognized the potential value and growth prospects of the company's products. The stock news for Durect Corp also reflects positive developments, such as collaborations with other pharmaceutical companies, advancements in its pipeline, and favorable analyst recommendations. These news articles highlight the potential for Durect Corp's stock to continue its upward trajectory.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Dr. James E. Brown D.V.M.
Headquarters
Cupertino
Employees
72
Exchange
NASDAQ
add Durect to watchlist

Keep an eye on Durect

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Durect's (DRRX) price per share?

The current price per share for Durect (DRRX) is $1.34. The stock has seen a price change of -$0.03 recently, indicating a -2.19% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Durect (DRRX)?

For Durect (DRRX), the 52-week high is $3.14, which is 134.33% from the current price. The 52-week low is $0.47, the current price is 185.11% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Durect (DRRX) a growth stock?

Durect (DRRX) has shown an average price growth of 0.41% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Durect as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Durect (DRRX) stock price performance year to date (YTD)?

As of the latest data, Durect (DRRX) has a year-to-date price change of 141.44%. Over the past month, the stock has experienced a price change of 0.37%. Over the last three months, the change has been -11.26%. Over the past six months, the figure is 7.2%. Looking at a longer horizon, the five-year price change stands at -93.94%.
help

Is Durect (DRRX) a profitable company?

Durect (DRRX) has a net income of -$27.62M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 79.91% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -156.79% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.55M, although specific revenue growth data is currently not available. The gross profit is $6.83M. Operating income is noted at -$36.88M. Furthermore, the EBITDA is -$24.93M.
help

What is the market capitalization of Durect (DRRX)?

Durect (DRRX) has a market capitalization of $41.59M. The average daily trading volume is 80.22K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media